Correlation Between Humacyte and Puma Biotechnology
Can any of the company-specific risk be diversified away by investing in both Humacyte and Puma Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Humacyte and Puma Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Humacyte and Puma Biotechnology, you can compare the effects of market volatilities on Humacyte and Puma Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Humacyte with a short position of Puma Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Humacyte and Puma Biotechnology.
Diversification Opportunities for Humacyte and Puma Biotechnology
-0.48 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Humacyte and Puma is -0.48. Overlapping area represents the amount of risk that can be diversified away by holding Humacyte and Puma Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Puma Biotechnology and Humacyte is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Humacyte are associated (or correlated) with Puma Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Puma Biotechnology has no effect on the direction of Humacyte i.e., Humacyte and Puma Biotechnology go up and down completely randomly.
Pair Corralation between Humacyte and Puma Biotechnology
Given the investment horizon of 90 days Humacyte is expected to under-perform the Puma Biotechnology. In addition to that, Humacyte is 1.52 times more volatile than Puma Biotechnology. It trades about -0.12 of its total potential returns per unit of risk. Puma Biotechnology is currently generating about 0.11 per unit of volatility. If you would invest 274.00 in Puma Biotechnology on September 18, 2024 and sell it today you would earn a total of 18.00 from holding Puma Biotechnology or generate 6.57% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Humacyte vs. Puma Biotechnology
Performance |
| Timeline |
| Humacyte |
| Puma Biotechnology |
Humacyte and Puma Biotechnology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Humacyte and Puma Biotechnology
The main advantage of trading using opposite Humacyte and Puma Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Humacyte position performs unexpectedly, Puma Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Puma Biotechnology will offset losses from the drop in Puma Biotechnology's long position.The idea behind Humacyte and Puma Biotechnology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| Puma Biotechnology vs. Ultragenyx | Puma Biotechnology vs. Crinetics Pharmaceuticals | Puma Biotechnology vs. Arvinas | Puma Biotechnology vs. Revolution Medicines |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Other Complementary Tools
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Transaction History View history of all your transactions and understand their impact on performance |